iFirst Medical Technologies

iFirst Medical Technologies was founded with the mission to revolutionize coagulation diagnostics through its lifesaving blood analysis platform. The company aims to set a new standard of care in diagnosing coagulation disorders, which are a leading cause of death globally. Their core product is an advanced viscoelastic coagulation diagnostic system that can be used anytime and anywhere, including at the point of care and point of injury. This system leverages iPhone-based technology to provide critical information quickly, aiding in the timely treatment of thrombosis and trauma.

Notable affiliated individuals and investors include experts in medical technology and healthcare innovation, though specific names are not provided. Key achievements for iFirst Medical Technologies include the development and deployment of their portable diagnostic system, which has the potential to significantly reduce mortality rates associated with coagulation disorders. The overall impact of the company lies in its ability to provide rapid, accurate diagnostics that can save lives in critical situations.